Inspira Technologies Oxy B.H.N. Ltd. (IINN)
NASDAQ: IINN · IEX Real-Time Price · USD
1.210
-0.060 (-4.72%)
At close: Jul 19, 2024, 4:00 PM
1.100
-0.110 (-9.09%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Company Description

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure.

Its lead product is the INSPIRA augmented respiration technology (Gen 2) device, a life support designed to provide Adaptive Blood Oxygenation that to elevate and stabilize declining oxygen saturation levels.

The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N.

Ltd. in July 2020. Inspira Technologies Oxy B.H.N.

Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.

Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy B.H.N. logo
Country Israel
Founded 2018
IPO Date Jul 14, 2021
Industry Medical Devices
Sector Healthcare
Employees 42
CEO Dagi Shahar Ben-Noon

Contact Details

Address:
Hatidhar 2, 11th Floor
Ra'anana, L3 4366504
Israel
Phone 972-9-9664488
Website inspira-technologies.com

Stock Details

Ticker Symbol IINN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $5.51
CIK Code 0001837493
CUSIP Number M53637100
ISIN Number IL0011715781
SIC Code 3841

Key Executives

Name Position
Dagi Shahar Ben-Noon Co-Founder, Chief Executive Officer and Director
Joe Hayon Co-Founder, President and Director
Yafit Tehila Chief Financial Officer
Avi Shabtai Chief Operating Officer and Vice President of Research and Development
Daniella Yeheskely-Hayon Ph.D. Chief Technology Officer
Meshira Greenberg Administrative Manager
Adi Shmueli Marketing and Communications Manager

Latest SEC Filings

Date Type Title
Jul 11, 2024 6-K Report of foreign issuer
Jun 20, 2024 6-K Report of foreign issuer
Jun 18, 2024 6-K/A Filing
Jun 18, 2024 424B5 Filing
Jun 17, 2024 6-K Report of foreign issuer
Jun 13, 2024 6-K Report of foreign issuer
Jun 11, 2024 144 Filing
May 28, 2024 6-K Report of foreign issuer
May 23, 2024 EFFECT Notice of Effectiveness
May 20, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers